A detailed history of Horizon Investments, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Horizon Investments, LLC holds 48,524 shares of BMY stock, worth $2.86 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
48,524
Previous 33,092 46.63%
Holding current value
$2.86 Million
Previous $1.37 Million 82.75%
% of portfolio
0.06%
Previous 0.03%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $612,033 - $798,606
15,432 Added 46.63%
48,524 $2.51 Million
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $15,295 - $20,136
-380 Reduced 1.14%
33,092 $1.37 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $452,835 - $513,427
9,438 Added 39.27%
33,472 $1.82 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $1.35 Million - $1.62 Million
-27,927 Reduced 53.75%
24,034 $1.23 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $10,651 - $11,910
-184 Reduced 0.35%
51,961 $3.02 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $187,052 - $207,692
2,936 Added 5.97%
52,145 $3.33 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $626,347 - $710,419
-9,532 Reduced 16.23%
49,209 $3.41 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $2.6 Million - $3.07 Million
-37,907 Reduced 39.22%
58,741 $4.19 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $7,662 - $4.53 Million
58,939 Added 156.3%
96,648 $6.82 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $4.4 Million - $4.84 Million
-60,539 Reduced 61.62%
37,709 $2.9 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $1.88 Million - $2.26 Million
30,655 Added 45.35%
98,248 $7.18 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $222,403 - $259,270
4,147 Added 6.54%
67,593 $4.18 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $2.37 Million - $2.78 Million
-40,128 Reduced 38.74%
63,446 $3.75 Million
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $2.66 Million - $2.9 Million
43,010 Added 71.02%
103,574 $6.87 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $3.59 Million - $4.04 Million
60,564 New
60,564 $3.82 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $2.73 Million - $3.1 Million
-47,307 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $4.41 Million - $4.89 Million
-76,825 Reduced 61.89%
47,307 $2.83 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $4.56 Million - $5.33 Million
83,161 Added 202.98%
124,132 $7.24 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $2.55 Million - $3.71 Million
-54,991 Reduced 57.3%
40,971 $2.27 Million
Q4 2019

Feb 14, 2020

SELL
$49.21 - $64.19 $399,782 - $521,479
-8,124 Reduced 7.81%
95,962 $6.16 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $3.35 Million - $3.97 Million
78,331 Added 304.14%
104,086 $5.23 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $887,670 - $981,569
19,894 Added 339.43%
25,755 $1.17 Million
Q1 2019

May 16, 2019

BUY
$45.12 - $53.8 $264,448 - $315,321
5,861 New
5,861 $277,000
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $822,982 - $1.03 Million
-16,287 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$59.92 - $68.98 $975,917 - $1.12 Million
16,287 New
16,287 $1.03 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.